In a groundbreaking study published in the in Proceedings of the National Academy of Sciences (PNAS), scientists at Pacific ...

DNA doesn’t just sit still inside our cells — it folds, loops, and rearranges in ways that shape how genes behave.

Vitamin B12 is a vital nutrient that plays numerous key roles in maintaining health. It is available in different forms and can be found in both food and supplements. A recent review suggests that the ...

Depending on the type, some vitamins and minerals can be taken at any time of day, with or without food, while others require ...

Researchers have discovered how cells activate a last-resort DNA repair system when severe damage strikes. When genetic tangles overwhelm normal repair pathways, cells flip on a fast but error-prone ...

Precise replication of genetic material is essential to maintain genome stability. DNA replication is a tightly regulated process that ensues faithful copies of DNA molecules to daughter cells during ...

Every researcher knows the frustration: your groundbreaking experiment is on hold because the DNA sequence you need is "unmanufacturable". Or worse, after weeks of waiting, the oligos arrive with ...

Here’s what you’ll learn when you read this story: We are generating staggering amounts of data every day. Data centers just can’t keep up with the demand. With data storage needs expected to soar in ...

EXCLUSIVE: Magnolia Pictures will be opening its Toronto Film Festival acquisition Normal on April 17, 2026 in 2,000 theaters, the distributor’s widest release in its 24-year history. Normal, which we ...

Liquid biopsies analyze materials like circulating tumor DNA (ctDNA) in the blood to provide a non-invasive look at a cancer’s genetic profile. They are highly effective for tracking tumor evolution, ...

Major biotech companies that churn out made-to-order DNA for scientists have protections in place to keep dangerous biological material out of the hands of would-be evil-doers. They screen their ...

Ansa Biotechnologies hauled in a total of $54.4 million in an oversubscribed series B round of financing that will be used to expand the company’s DNA synthesis production capacity in the U.S. The San ...